Publications by authors named "Joseph J Eron"

98Publications

Evaluating the Efficacy of Therapies in COVID-19 Patients.

Clin Infect Dis 2020 Aug 21. Epub 2020 Aug 21.

University of North Carolina, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciaa1231DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454372PMC
August 2020

Estimating a Set of Mortality Risk Functions with Multiple Contributing Causes of Death.

Epidemiology 2020 Sep;31(5):704-712

Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/EDE.0000000000001225DOI Listing
September 2020

Curing HIV: Seeking to Target and Clear Persistent Infection.

Cell 2020 04 26;181(1):189-206. Epub 2020 Mar 26.

International Center for the Advancement of Translational Science, Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Center for AIDS Research, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2020.03.005DOI Listing
April 2020

Opioid misuse among persons with HIV engaged in care in the Southeastern US.

AIDS Care 2019 Dec 8:1-6. Epub 2019 Dec 8.

Division of Infectious Diseases, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09540121.2019.1699644DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276291PMC
December 2019

Hospitalization Rates and Outcomes Among Persons Living With Human Immunodeficiency Virus in the Southeastern United States, 1996-2016.

Clin Infect Dis 2020 Oct;71(7):1616-1623

Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciz1043DOI Listing
October 2020

Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus-uninfected Individuals in HPTN 077.

Clin Infect Dis 2020 01;70(2):319-322

Division of Infectious Diseases, Department of Medicine, Center for AIDS Research and Education & Center for HIV Prevention, David Geffen School of Medicine at University of California, Los Angeles.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciz439DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938971PMC
January 2020

Evolution of HIV-1 drug resistance after virological failure of first-line antiretroviral therapy in Lusaka, Zambia.

Antivir Ther 2019 ;24(4):291-300

UNC Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP3299DOI Listing
June 2020

Estimating Human Immunodeficiency Virus (HIV) Prevention Effects in Low-incidence Settings.

Epidemiology 2019 05;30(3):358-364

From the Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/EDE.0000000000000966DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456405PMC
May 2019

Prediction of HIV Transmission Cluster Growth With Statewide Surveillance Data.

J Acquir Immune Defic Syndr 2019 02;80(2):152-159

Institute for Global Health and Infectious Diseases, The University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001905DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692892PMC
February 2019

HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals.

Mol Ther 2018 10 21;26(10):2496-2506. Epub 2018 Sep 21.

UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2018.08.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171327PMC
October 2018

Prevalence and Transmission Dynamics of HIV-1 Transmitted Drug Resistance in a Southeastern Cohort.

Open Forum Infect Dis 2018 Aug 20;5(8):ofy178. Epub 2018 Jul 20.

Division of Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ofid/ofy178DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101542PMC
August 2018

Acute HIV Infection and CD4/CD8 Ratio Normalization After Antiretroviral Therapy Initiation.

J Acquir Immune Defic Syndr 2018 12;79(4):510-518

Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001843DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203616PMC
December 2018

Leveraging Phylogenetics to Understand HIV Transmission and Partner Notification Networks.

J Acquir Immune Defic Syndr 2018 08;78(4):367-375

Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001695DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058319PMC
August 2018

T cells establish and maintain CNS viral infection in HIV-infected humanized mice.

J Clin Invest 2018 07 4;128(7):2862-2876. Epub 2018 Jun 4.

Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI98968DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026008PMC
July 2018

Sensitivity Analyses for Misclassification of Cause of Death in the Parametric G-Formula.

Am J Epidemiol 2018 08;187(8):1808-1816

School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/aje/kwy028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070049PMC
August 2018

Pretreatment integrase strand transfer inhibitor resistance in North Carolina from 2010-2016.

AIDS 2017 10;31(16):2235-2244

aDivision of Global Health and Infectious Diseases bDepartment of Epidemiology, UNC Gillings School of Global Public Health, University of North Carolina, Chapel Hill cDivision of HIV/AIDS, North Carolina Department of Public Health, Raleigh, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001611DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761699PMC
October 2017

Pretreatment integrase strand transfer inhibitor resistance in North Carolina from 2010-2016.

AIDS 2017 10;31(16):2235-2244

aDivision of Global Health and Infectious Diseases bDepartment of Epidemiology, UNC Gillings School of Global Public Health, University of North Carolina, Chapel Hill cDivision of HIV/AIDS, North Carolina Department of Public Health, Raleigh, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001611DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761699PMC
October 2017

Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients.

PLoS One 2017 10;12(7):e0180843. Epub 2017 Jul 10.

Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0180843PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507276PMC
September 2017

Effects of Health Insurance Interruption on Loss of Hypertension Control in Women With and Women Without HIV.

J Womens Health (Larchmt) 2017 12 6;26(12):1292-1301. Epub 2017 Jul 6.

1 Department of Epidemiology, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jwh.2016.6308DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733655PMC
December 2017

Incomplete viral suppression and mortality in HIV patients after antiretroviral therapy initiation.

AIDS 2017 09;31(14):1989-1997

aDepartment of Epidemiology bCenter for AIDS Research cDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina dDivision of Epidemiology, Ohio State University, Columbus, Ohio eJohns Hopkins University, Baltimore, Maryland fUniversity of Washington, Seattle, Washington gUniversity of California, San Diego, California hHarvard University, Cambridge, Massachusetts iUniversity of California, San Francisco, California jDivision of Infectious Diseases, Department of Medicine, Center for Global Health, Feinberg School of Medicine, Northwestern University, Chicago, Illinois kDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695564PMC
September 2017

HIV Care Initiation Delay Among Rural Residents in the Southeastern United States, 1996 to 2012.

J Acquir Immune Defic Syndr 2017 10;76(2):171-176

*Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC; †Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC; ‡Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL; and §Department of Epidemiology, The Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001483DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850947PMC
October 2017

Increased Persistence of Initial Treatment for HIV Infection With Modern Antiretroviral Therapy.

J Acquir Immune Defic Syndr 2017 10;76(2):111-115

Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001481DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597479PMC
October 2017

Rising prevalence of non-B HIV-1 subtypes in North Carolina and evidence for local onward transmission.

Virus Evol 2017 Jan 24;3(1):vex013. Epub 2017 May 24.

Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ve/vex013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442504PMC
January 2017

Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population.

J Acquir Immune Defic Syndr 2017 08;75(5):568-576

*Department of Medicine, University of Washington School of Medicine, Seattle, WA; †Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; ‡Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC; §Department of Medicine, University of Alabama School of Medicine, Birmingham, AL; ‖Department of Medicine, University of California San Diego, San Diego, CA; ¶Kaiser Permanente Division of Research, Oakland, CA; #Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN; **Department of Epidemiology, University of Washington School of Public Health, Seattle, WA; ††Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; ‡‡Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL; §§Department of Medicine, George Washington University School of Medicine, Washington, DC; ‖‖Department of Clinical Investigations, Whitman Walker Health, Washington, DC; ¶¶Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA; ##Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA; ***Department of Medicine, Yale School of Public Health, New Haven, CT; †††Department of Infectious Diseases, San Leandro Medical Center, San Leandro, CA; and ‡‡‡Department of Medicine, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001450DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522001PMC
August 2017

US Black Women and Human Immunodeficiency Virus Prevention: Time for New Approaches to Clinical Trials.

Clin Infect Dis 2017 Jul;65(2):324-327

Department of Medicine, University of North Carolina School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/cix313DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850546PMC
July 2017

Brief Report: Longitudinal Opioid Use Among HIV-Infected Patients, 2000 to 2014.

J Acquir Immune Defic Syndr 2017 05;75(1):77-80

*Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; and †Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001321DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388582PMC
May 2017